Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New erythromycin derivatives from Abbott

June 25, 1997

Merck & Co. describes compound active against fungi and P. carinii

June 25, 1997

Antibacterial agents from Ortho

June 24, 1997

Triazole antifungals under development

June 20, 1997

New sordarin derivatives from Glaxo Wellcome

June 20, 1997

New polyene from SPA compared to amphotericin B

June 20, 1997

New antifungals under development

June 20, 1997

Crystal structure of BPI described by Xoma/UCLA

June 20, 1997

Antifungal activity of nikkomycin Z alone and in combination with azoles

June 20, 1997

Trovafloxacin modulates the in vivo activity of antifungal agents

June 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...